MARKET CLOSE: NZ shares rise as vaccine trial boosts global sentiment

Dan Brunskill
Wed, 15 Jul 2020

New Zealand shares rose for a third day as investors welcomed interim results of a covid-19 vaccine trial which showed a positive immune response to the virus. The S&P/NZX 50 Index rose 116.38 points, or 1 percent, to 11,610.52. Within the index, 34 stocks rose and 16 fell. Turnover was $186.9 million. The experimental vaccine, developed by biotech company Moderna, safely induced an immune response against covid-19 in all 45 participants, researchers reported in The New England Journal of Medicine. Moderna has now announced that a phase 3...
More evidence the post-lockdown bounce is fading
Rebecca Howard | Mon, 10 Aug 2020

The preliminary August reading of the ANZ Business Outlook adds to the view the post-lockdown rebound has run its course.

Law & Regulation
Turners couldn’t handle unorthodox approach of used car dealer, court told
Victoria Young | Mon, 10 Aug 2020

Turners Automotive Group couldn’t handle the unorthodox business approach of Brandon Orlandini, the used car dealer whose business it bought, the High Court heard today. Orlandini’s company, Turnov...

First move towards border-opening as govt consults with Cook Islands
Pattrick Smellie | Mon, 10 Aug 2020

The New Zealand and Cook Islands governments will spend the next 10-to-14 days assessing whether the systems are in place to allow a travel 'bubble' to open between the two countries before the end of...

Partner content
Don’t fear the robots. How software can help your business succeed

New Zealand businesses are on the road to recovery from the economic impact of the Covid-19 crisis but they, like corporates around the world, are having to change their operational practices.